Calverley et al used a simple symptom score to monitor patients with chronic obstructive pulmonary disease (COPD). This can be used to detect disease progression and measure the effectiveness of interventions. The authors are from universities in England, Belgium, Denmark and Norway engaged in the TRISTAN study group.